Corporate R&D StrategyNVIDIA's BioNeMo Becomes Pharma's AI Backbone as Novo Nordisk Offloads Parkinson's Risk to AI PartnerVia News Editorial Team•Jun 27, 2026
Pharma FinanceNovo Nordisk Licenses Parkinson's Program and Exits Cell Therapy as AI Reshapes Pharma R&DVia News Editorial Team•May 16, 2026